UroGen Pharma Ltd.
USD36.69
+0.62 (+1.72%)
CEO
Elizabeth Barrett
IPO Date
2017-05-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$35.95
Prev. Close
$36.07
Day Low
$35.85
Day High
$36.75
52W Low
$12.73
52W High
$36.75
Market Cap
$1.79B
Volume
0.07M
| -3.6 |
| 31 Dec 2023 | FY | 88.7% | -123.6% | 156.8% | -57.3% | -1.52 | 5.42 | -4.2 |
| 31 Dec 2022 | FY | 88.1% | -170.6% | 122.9% | -80.9% | -1.11 | 5.39 | -1.8 |
| 31 Dec 2021 | FY | 89.3% | -230.7% | -1317.2% | -92.5% | 0.05 | 5.11 | -1.9 |
| 31 Dec 2020 | FY | 91.4% | -1088.9% | -133.3% | -105.3% | 0.02 | 5.39 | -3.1 |
| 31 Dec 2019 | FY | 100.0% | -584144.4% | -58.3% | -52.0% | 0.01 | 7.63 | -6.5 |
| 31 Dec 2018 | FY | -59.8% | -6707.2% | -84.0% | -73.1% | 0.00 | 7.59 | -9.0 |
| 31 Dec 2017 | FY | 92.6% | -245.2% | -29.2% | -26.5% | 0.00 | 10.59 | -18.8 |
| 31 Dec 2016 | FY | 99.8% | -11.1% | -11.9% | -8.4% | 0.00 | 7.03 | -86.2 |
| -10.9 |
| 30 Sept 2025 | Q3 | 88.1% | -121.3% | 28.9% | -18.0% | -1.13 | 3.99 | -7.2 |
| 30 Jun 2025 | Q2 | 85.3% | -206.2% | 53.5% | -23.9% | -1.37 | 4.14 | -3.3 |
| 31 Mar 2025 | Q1 | 88.5% | -216.5% | 94.4% | -17.7% | -2.69 | 5.65 | -3.0 |
| 31 Dec 2024 | Q4 | 89.9% | -152.7% | 426.1% | -13.1% | -14.02 | 6.01 | -3.3 |
| 30 Sept 2024 | Q3 | 90.3% | -93.9% | -92.8% | -7.8% | 4.78 | 9.00 | -5.8 |
| 30 Jun 2024 | Q2 | 89.8% | -152.9% | -110.2% | -11.9% | 3.24 | 8.15 | -4.5 |
| 31 Mar 2024 | Q1 | 90.8% | -171.9% | 80.4% | -16.1% | -2.47 | 7.47 | -3.7 |
| 31 Dec 2023 | Q4 | 90.3% | -110.6% | 39.9% | -14.6% | -1.54 | 5.42 | -5.2 |